Table 2 POMS2 TMD (total mood disturbance) scores and subscores after the Uchida-Kraepelin (U-K) test at 8 weeks and its change from baseline.

From: Lactococcus cremoris YRC3780 improves subjective stress response in the Uchida-Kraepelin test: a randomized, double-blind, placebo-controlled study

 

Placebo

YRC3780

Baseline

Week 8

Baseline

Week 8

TMD score after U-K test

60.9 ± 10.3

53.2 ± 10.8

60.3 ± 11.6

50.0 ± 9.7 *

Change in score from baseline (points)

–7.7 ± 6.0

–10.4 ± 9.0 *

Percentage change from baseline (%)

–12.6 ± 9.7

–16.2 ± 12.5

AH score difference after U-K test

57.0 ± 11.3

50.5 ± 11.3

54.9 ± 11.9

47.0 ± 9.3

Change in score from baseline (points)

–6.5 ± 10.8

–7.9 ± 11.0

Percentage change from baseline (%)

–10.0 ± 18.8

–12.5 ± 16.5

CB score difference after U-K test

61.2 ± 12.4

53.8 ± 12.1

62.2 ± 12.6

51.9 ± 10.7

Change in score from baseline (points)

–7.4 ± 5.8

–10.3 ± 10.4

Percentage change from baseline (%)

–11.9 ± 8.9

–15.3 ± 14.1

DD score difference after U-K test

58.9 ± 11.7

51.8 ± 10.4

57.6 ± 12.2

48.7 ± 9.3

Change in score from baseline (points)

–7.1 ± 6.9

–8.9 ± 9.5

Percentage change from baseline (%)

–11.2 ± 11.1

–14.0 ± 13.9

FI score difference after U-K test

62.1 ± 9.3

53.7 ± 11.0

61.3 ± 10.9

51.1 ± 11.4

Change in score from baseline (points)

–8.4 ± 7.6

–10.2 ± 10.1

Percentage change from baseline (%)

–13.5 ± 12.4

–15.9 ± 14.6

TA score difference after U-K test

59.7 ± 10.5

51.7 ± 10.7

59.8 ± 11.5

49.9 ± 10.5

Change in score from baseline (points)

–8.1 ± 7.2

–9.9 ± 9.2

Percentage change from baseline (%)

–13.1 ± 11.7

–15.8 ± 13.8

VA score difference after U-K test

45.2 ± 9.1

45.7 ± 9.6

45.0 ± 9.0

47.3 ± 9.2

Change in score from baseline (points)

0.5 ± 7.2

2.2 ± 7.9

Percentage change from baseline (%)

2.1 ± 15.7

6.6 ± 16.9

F score difference after U-K test

46.8 ± 10.8

45.2 ± 11.3

43.2 ± 11.2

44.2 ± 10.4

Change in score from baseline (points)

–1.6 ± 8.6

1.1 ± 9.3

Percentage change from baseline (%)

–2.0 ± 18.0

5.5 ± 21.8

  1. Data are shown as means ± SD (Placebo, n = 53, YRC3780, n = 54).
  2. Significant differences (*p < 0.05, ANCOVA with each initial value as a covariate) between the placebo and YRC3780 groups are indicated.
  3. TA, Tension–Anxiety, DD, Depression–Dejection, AH, Anger–Hostility, CB, Confusion–Bewilderment, AH, Anger–Hostility, VA, Vigor–Activity FI, Fatigue–Inertia, F, Friendliness.